HCL Technologies to help Finastra drive digital transformation in South Korea and Taiwan

HCL Technologies to help Finastra drive digital transformation in South Korea and Taiwan

HCL Technologies said that it has expanded its partnership with Finastra, a pure-play software vendor for the financial services industry, for driving digital transformation in South Korea and Taiwan. As part of the partnership, the Indian IT services provider will tap its next-generation digital transformation and service capabilities for bringing Fusion Cash Management and Fusion […]

Strides Pharma, TLC partner to bring Black Fungus drug AmphoTLC to India

Strides Pharma, TLC partner to bring Black Fungus drug AmphoTLC to India

Strides Pharma Science Limited has entered into a partnership with Taiwan-based TLC to distribute the latter’s liposomal amphotericin B drug in India for the treatment of Black Fungus in Covid-19 patients under the AmphoTLC brand. The agreement between the parties follows the approval of TLC’s new drug application (NDA) of Amphotericin B Liposome for Injection […]

Cadila Healthcare to bring Black Fungus drug AmphoTLC to India

Cadila Healthcare to bring Black Fungus drug AmphoTLC to India

Cadila Healthcare (also known as Zydus Cadila) has signed a license supply and commercialization agreement with Taiwanese pharma company TLC to commercialize the latter’s Black Fungus drug – AmphoTLC (Amphotericin B Liposome for Injection 50mg) in India. As per the terms of the deal, TLC will manufacture and supply AmphoTLC on a non-exclusive basis to […]

Hero MotoCorp to form battery swapping joint venture with Taiwan’s Gogoro

Hero MotoCorp to form battery swapping joint venture with Taiwan’s Gogoro

Hero MotoCorp has entered into a partnership with Taiwanese battery swapping platform provider Gogoro with an aim to fast tracking the transition to sustainable electric mobility in India. The Indian motorcycles and scooters manufacturer will create a battery swapping joint venture to bring the battery swapping platform of Gogoro to India. Hero MotoCorp will be […]

Foresee Pharmaceuticals begins FP-025 phase 2/3 trial in Covid-19 associated ARDS

Foresee Pharmaceuticals begins FP-025 phase 2/3 trial in Covid-19 associated ARDS

Foresee Pharmaceuticals has started patient dosing in a phase 2/3 trial of FP-025 in adults having severe to critical Covid-19 with associated acute respiratory distress syndrome (ARDS). According to the Taiwanese pharma company, FP-025 is an oral small molecule inhibitor of MMP-12, whose main functions are the modulation of various components such as elastin and […]

PharmaEngine, Sentinel Oncology partner to advance SOL-578 Chk1 inhibitor

PharmaEngine, Sentinel Oncology partner to advance SOL-578 Chk1 inhibitor

PharmaEngine has signed a collaboration and license deal with UK-based Sentinel Oncology for advancing the new drug development of SOL-578, a checkpoint kinase 1 inhibitor (Chk1 inhibitor). As per the agreement, the Taiwanese pharma company will finance the investigational new drug (IND) enabling studies for SOL-578. Sentinel Oncology is a drug discovery company engaged in […]

CenterLab’s anti-diabetic drug candidate CS02 meets primary endpoint in phase 2 trial

CenterLab’s anti-diabetic drug candidate CS02 meets primary endpoint in phase 2 trial

Taiwanese pharma company Center Laboratories (CenterLab) said that its anti-diabetic drug candidate CS02 has met the primary endpoint of a phase 2 clinical trial. According to Center Laboratories, the orally administered small molecule drug candidate delivered significant reductions in glycated hemoglobin (HbA1c) in comparison to the placebo group. The phase 2 clinical trial is a […]